Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Citi
Healthtrust
Cantor Fitzgerald
Teva
Fuji
Baxter
US Department of Justice
Medtronic

Generated: June 19, 2018

DrugPatentWatch Database Preview

ERGOMAR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ergomar patents expire, and what generic alternatives are available?

Ergomar is a drug marketed by Tersera Theraps Llc and is included in one NDA.

The generic ingredient in ERGOMAR is ergotamine tartrate. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergotamine tartrate profile page.
Drug patent expirations by year for ERGOMAR
Pharmacology for ERGOMAR
Ingredient-typeErgotamines
Drug ClassErgotamine Derivative
Synonyms for ERGOMAR
(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0;{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
(5''alpha)-12''-hydroxy-2''-methyl-5''-(phenylmethyl)ergotoman-3'',6'',18-trione
(5''alpha)-5''-benzyl-12''-hydroxy-2''-methyl-3'',6'',18-trioxoergotaman
(5'A)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate(2:1)
(5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
(5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman
1080650-16-3
113-15-5
12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione
12''-hydroxy-2''-methyl-5''alpha-(phenylmethyl)ergotaman-3'',6'',18-trione
379-79-3 (2:1 tartrate salt)
6915-20-4
98260-30-1
AB01275473-01
AC1L1QJJ
AKOS015896505
Ambotz113-15-5
Avetol
BDBM50027065
BRN 0078890
C33H35N5O5
CHEBI:64318
CHEMBL442
Cornutamin
Cornutamine
D01TSI
D07906
DB00696
DTXSID9043774
EINECS 204-023-9
Ergam
Ergate
Ergomar (TN)
Ergonsvine
Ergostat
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-(9CI)
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
Ergotamin
Ergotamina
Ergotamina [INN-Spanish]
ERGOTAMINE
Ergotamine (INN)
ERGOTAMINE (SEE ALSO: ERGOTAMINE TARTRATE (CAS 379-79-3))
Ergotamine [INN:BAN]
Ergotamine bitartrate
Ergotamine hemitartrate
ergotamine tartrate
Ergotamine tartrate (VAN)
Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate
Ergotamine, tartrate (2:1)
Ergotamine, tartrate (2:1) (salt) (8CI)
ergotaminum
Ergotaminum [INN-Latin]
Ergotartrate
Ergoton-A
ERM
ETIN
Exmigra
Femergin
Gotamine tartrate
GTPL149
Gynergen
HMS2089H22
HSDB 4076
I06-2464
Lingraine
Lingran
LS-564
Medihaler ergotamine
Migretamine
N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-methyl-[?]carboxamide
Neo-ergotin
NSC 95090
PR834Q503T
Rigetamin
SCHEMBL1483
Secagyn
Secupan
Temigran
TX-012337
UNII-PR834Q503T
Wigrettes
ZINC52955754

US Patents and Regulatory Information for ERGOMAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc ERGOMAR ergotamine tartrate TABLET;SUBLINGUAL 087693-001 Feb 24, 1983 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Colorcon
Chubb
Harvard Business School
Teva
Julphar
McKesson
UBS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.